JP2002502369A5 - - Google Patents

Download PDF

Info

Publication number
JP2002502369A5
JP2002502369A5 JP1998549741A JP54974198A JP2002502369A5 JP 2002502369 A5 JP2002502369 A5 JP 2002502369A5 JP 1998549741 A JP1998549741 A JP 1998549741A JP 54974198 A JP54974198 A JP 54974198A JP 2002502369 A5 JP2002502369 A5 JP 2002502369A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998549741A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002502369A (ja
JP4699576B2 (ja
Filing date
Publication date
Priority claimed from GBGB9715481.9A external-priority patent/GB9715481D0/en
Priority claimed from US09/059,504 external-priority patent/US6051557A/en
Application filed filed Critical
Priority claimed from PCT/CA1998/000497 external-priority patent/WO1998052600A1/en
Publication of JP2002502369A publication Critical patent/JP2002502369A/ja
Publication of JP2002502369A5 publication Critical patent/JP2002502369A5/ja
Application granted granted Critical
Publication of JP4699576B2 publication Critical patent/JP4699576B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54974198A 1997-05-16 1998-05-15 胃腸管上部の機能を強化する方法 Expired - Fee Related JP4699576B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US4675497P 1997-05-16 1997-05-16
US60/046,754 1997-05-16
GBGB9715481.9A GB9715481D0 (en) 1997-07-23 1997-07-23 Methods of enhancing functioning of the upper gastrointestinal tract
GB9715481.9 1997-07-23
US09/059,504 US6051557A (en) 1997-05-16 1998-04-13 Methods of enhancing functioning of the upper gastrointestinal tract
US09/059,504 1998-04-13
US9715481.9 1998-04-13
PCT/CA1998/000497 WO1998052600A1 (en) 1997-05-16 1998-05-15 Methods of enhancing functioning of the upper gastrointestinal tract

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009171401A Division JP2009280598A (ja) 1997-05-16 2009-07-22 胃腸管上部の機能を強化する方法

Publications (3)

Publication Number Publication Date
JP2002502369A JP2002502369A (ja) 2002-01-22
JP2002502369A5 true JP2002502369A5 (enExample) 2005-07-14
JP4699576B2 JP4699576B2 (ja) 2011-06-15

Family

ID=27268946

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54974198A Expired - Fee Related JP4699576B2 (ja) 1997-05-16 1998-05-15 胃腸管上部の機能を強化する方法
JP2009171401A Pending JP2009280598A (ja) 1997-05-16 2009-07-22 胃腸管上部の機能を強化する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009171401A Pending JP2009280598A (ja) 1997-05-16 2009-07-22 胃腸管上部の機能を強化する方法

Country Status (13)

Country Link
EP (1) EP0981362B1 (enExample)
JP (2) JP4699576B2 (enExample)
CN (1) CN1264307B (enExample)
AT (1) ATE253375T1 (enExample)
AU (1) AU746633B2 (enExample)
BR (1) BR9808804A (enExample)
CA (1) CA2289652C (enExample)
DE (1) DE69819488T2 (enExample)
DK (1) DK0981362T3 (enExample)
ES (1) ES2210756T3 (enExample)
MX (1) MXPA99010523A (enExample)
PT (1) PT981362E (enExample)
WO (1) WO1998052600A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE253375T1 (de) * 1997-05-16 2003-11-15 Ontario Inc 1149336 Verwendung von glp-2 agonisten zur verbesserung der wirkung des oberen gastrointestinaltraktes
GB9905416D0 (en) * 1999-03-09 1999-05-05 Allelix Biopharma Small molecules having GLP-2 like activity
RU2164349C1 (ru) * 1999-07-27 2001-03-20 Нижегородская государственная медицинская академия Способ определения стоматологического статуса
WO2001041779A2 (en) * 1999-12-08 2001-06-14 1149336 Ontario Inc. Combined use of glp-2 receptor agonist and chemotherapeutic agent in treatment
US7186683B2 (en) 2000-09-18 2007-03-06 Sanos Bioscience A/S Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
PT1326630E (pt) * 2000-09-18 2008-09-02 Sanos Bioscience As Utilização de péptidos glp-2
US7371721B2 (en) 2000-09-18 2008-05-13 Sanos Bioscience A/S Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US7411039B2 (en) 2002-10-14 2008-08-12 Novo Nordisk A/S GLP-2 compounds, formulations, and uses thereof
DK1809318T3 (da) 2004-11-01 2013-09-08 Nps Pharma Inc Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet
DE602006020123D1 (de) † 2005-05-04 2011-03-31 Zealand Pharma As Glucagon-like-peptide-2- (glp-2-) analoga
AU2007319066B2 (en) * 2006-11-08 2013-09-19 Zealand Pharma A/S Selective glucagon-like-peptide-2 (GLP-2) analogues
US20110171164A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Polymer conjugates of glp-2-like peptides
JP5908478B2 (ja) * 2010-08-30 2016-04-26 エヌピーエス ファーマシューティカルズ インコーポレイテッドNps Pharmaceuticals, Inc. h「Gly2」GLP−2の固相合成
EA028929B1 (ru) 2012-05-03 2018-01-31 Зилэнд Фарма А/С Аналоги глюкагоноподобного пептида-2 (glp-2)
US20180200301A1 (en) * 2015-05-21 2018-07-19 Shanghai Institutes For Biological Sciences Chinese Academy Of Sciences Low-Oxygen-Treated Mesenchymal Stem Cell and Use Thereof
KR102502040B1 (ko) 2016-12-09 2023-02-24 질랜드 파마 에이/에스 아실화 glp-1/glp-2 이중 효능제
IL271245B2 (en) 2017-06-16 2023-10-01 Zealand Pharma As Dosing regimen for administration of glucagon-like peptide analog (GLP-2) 2
CN108273038B (zh) * 2018-03-16 2019-03-19 中国人民解放军军事科学院军事医学研究院 防治肠型放射病的药物组合物
CN110226566A (zh) * 2019-07-12 2019-09-13 南京中医药大学 一种放射性口腔黏膜炎动物模型的造模方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK27885A (da) * 1985-01-22 1986-07-23 Novo Industri As Fremstilling af peptider
US5990077A (en) * 1995-04-14 1999-11-23 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
EP2275438A1 (en) * 1996-04-12 2011-01-19 1149336 Ontario Inc. Glucagon-like peptide-2 analogs
ES2181054T3 (es) * 1996-12-06 2003-02-16 Amgen Inc Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.
US5952301A (en) * 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function
ATE253375T1 (de) * 1997-05-16 2003-11-15 Ontario Inc 1149336 Verwendung von glp-2 agonisten zur verbesserung der wirkung des oberen gastrointestinaltraktes

Similar Documents

Publication Publication Date Title
JP2000509912A5 (enExample)
JP2000507042A5 (enExample)
JP2000509637A5 (enExample)
JP2000510751A5 (enExample)
JP2000509635A5 (enExample)
JP2000509942A5 (enExample)
JP2002508132A5 (enExample)
JP2001511200A5 (enExample)
JP2001513826A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001516478A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508841A5 (enExample)
JP2001527608A5 (enExample)
JP2000508680A5 (enExample)
JP2000509853A5 (enExample)
JP2002505716A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)